February 28, 2017 Considerations for Requiring Subjects to Respond to PRO Instruments Collected Electronically This webinar provides an overview of specific considerations related to allowing subjects to opt out of responding to individual i
Biomarker Qualification: Collaboration, Strategy, and Implementation Biomarker Qualification: Collaboration, Strategy, and Implementation Webinar February 24th, 2017 Presenter: John Michael Sauer, Ph
Highlights from the 02 August CDISC Strategy Session The CDISC Strategy Session highlight video includes an interview with Cheryl Fitzer-Attas (CHDI Foundation) discussing the importa
February 28, 2017 Bring Your Own Device (BYOD) This webinar provides an overview of scientific, logistical, and regulatory considerations when using a BYOD approach to collect p
April 25, 2017 Second Annual Workshop on Clinical Outcome Assessments in Cancer Clinical Trials Event: Second Annual Workshop on Clinical Outcome Assessments in Cancer Clinical Trials Date: April 25, 2017 Location: Hyatt Rege
ReSeqTB Data Platform Now Available to Public January 17, 2017 TUCSON, Ariz., January 17, 2017 —The Rapid Drug Susceptibility Testing Consortium, coordinated by
December 1, 2017 Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy
March 2, 2017 Safety, Dosing, and Pharmaceutical Quality for Studies That Evaluate Medicinal Products (Including Biological Products) in Neonates Ward RM, Benjamin D, Barrett JS, Allegaert K, Portman R, Davis JM, Turner MA, and the International Neonatal Consortium. Safety, D